secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beta Bionics, Inc. (BBNX)
CIK:        0001674632
Form:       8-K
Filed at:   2025-01-31T23:59:59+00:00
Accession:  0001193125-25-018471
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 3.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beta Bionics closes upsized IPO of 13.8M shares at $17.00, raises $229.1M
-------------------------------------------------------------------------

- IPO of 13,800,000 shares at $17.00/share, including full exercise of underwriters' option for 1,800,000 additional shares.
- Gross proceeds to Beta Bionics from IPO total $212.1M; combined with concurrent private placement, aggregate proceeds $229.1M.
- Private placement: 1,000,000 shares sold to existing investor at IPO price of $17.00/share.
- Shares began trading on Nasdaq Global Market on January 30, 2025 under ticker BBNX.
- Lead bookrunners: BofA Securities, Piper Sandler, and Leerink Partners; Stifel bookrunner; Lake Street co-manager.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674632/000119312525018471/0001193125-25-018471-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674632/000119312525018471/d933339d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-018471

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer